Terms: = Lung cancer AND POLE, POLE1, 5426, FLJ21434, DKFZp434F222, ENSG00000177084 AND Treatment
42 results:
1. Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.
Dupain C; Gutman T; Girard E; Kamoun C; Marret G; Castel-Ajgal Z; Sablin MP; Neuzillet C; Borcoman E; Hescot S; Callens C; Trabelsi-Grati O; Melaabi S; Vibert R; Antonio S; Franck C; Galut M; Guillou I; Halladjian M; Allory Y; Cyrta J; Romejon J; Frouin E; Stoppa-Lyonnet D; Wong J; Le Tourneau C; Bièche I; Servant N; Kamal M; Masliah-Planchon J
BMC Biol; 2024 Feb; 22(1):43. PubMed ID: 38378561
[TBL] [Abstract] [Full Text] [Related]
2. Endometrial adenocarcinoma recurring in the lung: impact of molecular profile and role of local therapies on prognosis.
Luzarraga Aznar A; Bebia V; López-Gil C; Giraldo A; Montoya MP; Verges R; Jauregui A; Castellvi J; Pérez-Benavente A; Colás E; Gil-Moreno A; Cabrera S
Int J Gynecol Cancer; 2023 Oct; 33(10):1564-1571. PubMed ID: 37726197
[TBL] [Abstract] [Full Text] [Related]
3. Integrating pole/POLD1 mutated for immunotherapy treatment planning of advanced stage non-small cell lung cancer.
Zheng S; Cao Y; Randall J; Yu H; Thomas TO
Thorac Cancer; 2023 Aug; 14(23):2269-2274. PubMed ID: 37345618
[TBL] [Abstract] [Full Text] [Related]
4. DNA repair and immune checkpoint blockade response.
Guo JA; Alshalalfa M; Kim DY; Hoffman HI; Shiau C; Su J; Hwang WL; Mahal BA
Cancer Genet; 2022 Jun; 264-265():1-4. PubMed ID: 35245846
[TBL] [Abstract] [Full Text] [Related]
5. The Current and Evolving Role of Immunotherapy in Metastatic Colorectal cancer.
Silva VS; Riechelmann RP; Mello CA; Felismino T; Taboada R
Curr Cancer Drug Targets; 2022 Aug; 22(8):617-628. PubMed ID: 35209820
[TBL] [Abstract] [Full Text] [Related]
6. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
[TBL] [Abstract] [Full Text] [Related]
7. [Successful Re-Administration of Nivolumab in Patient with Metastatic Renal Cell Carcinoma : A Case Report].
Sasagawa H; Numakura K; Nakamura G; Kukimoto T; Kikuchi A; Sagehashi R; Yamamoto R; Koizumi A; Nara T; Kanda S; Saito M; Narita S; Inoue T; Satoh S; Habuchi T
Hinyokika Kiyo; 2021 Dec; 67(12):525-528. PubMed ID: 34991292
[TBL] [Abstract] [Full Text] [Related]
8. Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer.
Du F; Liu Y
J Clin Lab Anal; 2022 Jan; 36(1):e24141. PubMed ID: 34817097
[TBL] [Abstract] [Full Text] [Related]
9. Immune related endonucleases and GTPases are not associated with tumor response in patients with advanced non-small cell lung cancer treated with checkpoint inhibitors.
Ramdani HO; Falk M; Heukamp LC; Schatz S; Tiemann M; Wesseler C; Diehl L; Schuuring E; Groen HJM; Griesinger F
Pathol Res Pract; 2021 Nov; 227():153651. PubMed ID: 34673351
[TBL] [Abstract] [Full Text] [Related]
10. Poor performance status patient with long-lasting major response to pembrolizumab in advanced non-small-cell lung cancer with coexisting pole mutation and deficient mismatch repair pathway.
Vauchier C; Pluvy J; Theou-Anton N; Soussi G; Poté N; Brosseau S; Gounant V; Zalcman G
Lung Cancer; 2021 Oct; 160():28-31. PubMed ID: 34371300
[TBL] [Abstract] [Full Text] [Related]
11. Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance.
Shin SB; Kim CH; Jang HR; Yim H
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207738
[TBL] [Abstract] [Full Text] [Related]
12. High polymerase ε expression associated with increased CD8+T cells improves survival in patients with non-small cell lung cancer.
Min KW; Kim WS; Kim DH; Son BK; Oh YH; Kwon MJ; Lee HS; Lee SE; Kim IA; Moon JY; Kim KY; Park JH
PLoS One; 2020; 15(5):e0233066. PubMed ID: 32433714
[TBL] [Abstract] [Full Text] [Related]
13. Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non-small cell lung cancer patients.
Song P; Yang D; Wang H; Cui X; Si X; Zhang X; Zhang L
Thorac Cancer; 2020 Jun; 11(6):1647-1654. PubMed ID: 32342665
[TBL] [Abstract] [Full Text] [Related]
14. CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human lung and Colorectal cancer Cells.
Rogers RF; Walton MI; Cherry DL; Collins I; Clarke PA; Garrett MD; Workman P
Cancer Res; 2020 Apr; 80(8):1735-1747. PubMed ID: 32161100
[TBL] [Abstract] [Full Text] [Related]
15. Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies.
Qian J; Nie W; Lu J; Zhang L; Zhang Y; Zhang B; Wang S; Hu M; Xu J; Lou Y; Dong Y; Niu Y; Yan B; Zhong R; Zhang W; Chu T; Zhong H; Han B
Int J Cancer; 2020 Jun; 146(11):3124-3133. PubMed ID: 31583695
[TBL] [Abstract] [Full Text] [Related]
16. Primary Ewing sarcoma of the kidney.
Doroudinia A; Ahmadi S; Mehrian P; Pourabdollah M
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30696641
[TBL] [Abstract] [Full Text] [Related]
17. Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer.
Kang J; Chen HJ; Zhang XC; Su J; Zhou Q; Tu HY; Wang Z; Wang BC; Zhong WZ; Yang XN; Chen ZH; Ding Y; Wu X; Wang M; Fu JG; Yang Z; Zhang X; Shao YW; Wu YL; Yang JJ
Thorac Cancer; 2018 Sep; 9(9):1093-1103. PubMed ID: 29978950
[TBL] [Abstract] [Full Text] [Related]
18. [Epididymal liposarcoma with metastases to the retroperitoneal space and peritoneal cavity: A case report and literature review].
Li JL; Fan J
Zhonghua Nan Ke Xue; 2017 Dec; 23(12):1103-1106. PubMed ID: 29738182
[TBL] [Abstract] [Full Text] [Related]
19. Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.
Lu H; Yang S; Zhu H; Tong X; Xie F; Qin J; Han N; Wu X; Fan Y; Shao YW; Mao W
BMC Cancer; 2018 Mar; 18(1):251. PubMed ID: 29506494
[TBL] [Abstract] [Full Text] [Related]
20. RNA Sequencing Analysis Reveals Interactions between Breast cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis.
Sato R; Nakano T; Hosonaga M; Sampetrean O; Harigai R; Sasaki T; Koya I; Okano H; Kudoh J; Saya H; Arima Y
Biomed Res Int; 2017; 2017():8032910. PubMed ID: 28210624
[TBL] [Abstract] [Full Text] [Related]
[Next]
